Invention Grant
US08207350B2 Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome
有权
乙酰辅酶A羧化酶（ACC）抑制剂及其在糖尿病，肥胖症和代谢综合征中的应用
- Patent Title: Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome
- Patent Title (中): 乙酰辅酶A羧化酶（ACC）抑制剂及其在糖尿病，肥胖症和代谢综合征中的应用
-
Application No.: US12259090Application Date: 2008-10-27
-
Publication No.: US08207350B2Publication Date: 2012-06-26
- Inventor: Robert F. Keyes , Yu Gui Gu , Hing L. Sham
- Applicant: Robert F. Keyes , Yu Gui Gu , Hing L. Sham
- Applicant Address: US IL Abbott Park
- Assignee: Abbott Laboratories
- Current Assignee: Abbott Laboratories
- Current Assignee Address: US IL Abbott Park
- Agency: Michael Best & Friedrich LLP
- Agent Lisa V. Mueller
- Main IPC: A61K31/428
- IPC: A61K31/428 ; C07D277/64 ; C07D277/74
Abstract:
The present invention relates to compounds of formula (I) which inhibit acetyl-CoA carboxylase (ACC) and are useful for the prevention or treatment of metabolic syndrome, type II diabetes, obesity, atherosclerosis and cardiovascular diseases in humans.
Public/Granted literature
- US20090048298A1 Novel acetyl-CoA Carboxylase (ACC) Inhibitors and their use in Diabetes, Obesity and Metabolic Syndrome Public/Granted day:2009-02-19
Information query
IPC分类:
